Last reviewed · How we verify
NCT03210766
Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain
trial testing Nabilone in FBSS in 20 participants. Completed in 31 January 2016.
1 January 2015
Quick facts
| Lead sponsor | Azienda Ospedaliera Universitaria Policlinico "G. Martino" |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 1 September 2014 |
| Primary completion | 1 January 2015 |
| Estimated completion | 31 January 2016 |
Drugs / interventions tested
Conditions studied
- FBSS — all drugs for FBSS →
Sponsor
Azienda Ospedaliera Universitaria Policlinico "G. Martino"
Who can join
Adults 45 to 70, any sex, with FBSS. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the efficacy of oral administration of nabilone or THC/CBD administration in combination with spinal cord stimulation (SCS) in FBSS patients refractory to other available therapeutic strategies.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cannabinoids and spinal cord stimulation for the treatment of failed back surgery syndrome refractory pain.
Mondello E, Quattrone D, Cardia L, Bova G, et al · · 2018 · cited 16× · PMID 30233233 · DOI 10.2147/jpr.s166617
Verify or expand the search:
- PubMed search for NCT03210766
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nabilone
Trials testing the same drug.
- NCT05494437 — Effect of PP-01 on Cannabis Withdrawal Syndrome · Phase 2 · completed
- NCT05273320 — Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities · Phase 1 · completed
- NCT04880278 — Multimodal Assessment of Cannabinoid Target Engagement in Adults With Obsessive-Compulsive Disorder · Phase 1, PHASE2 · withdrawn
- NCT04801641 — A Pilot Trial of Nabilone for the Treatment of Obesity · Phase 2 · terminated
- NCT01517100 — The Role of Endocannabinoids in Insulin Production and Action · Phase 1 · completed
Other Azienda Ospedaliera Universitaria Policlinico "G. Martino" trials
Trials by the same sponsor.
- NCT07017244 — Effect of a Dietary Supplement vs Low-dosage Product on Infant Gastrointestinal Discomfort and Colics · NA · not yet recruiting
- NCT05903976 — De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent · Phase 3 · unknown
- NCT06123559 — Physical Exercise, Motor Activity and Depression in Post-mastectomy Pain Syndrome · completed
- NCT06123234 — Randomised Double-blind Active vs. Placebo Clinical Trial on the Effect of a Food Supplement on IBS in Children · NA · unknown
- NCT06218225 — Effect of an Immune-boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03210766 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera Universitaria Policlinico "G. Martino"
- Last refreshed: 16 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03210766.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing